Why the global biomaterials ecosystem needs a major rethink

The biomaterials manufacturing ecosystem is broken. Life-changing medical treatments rely on biomaterials, but prices are excessive, access is limited, and a handful of global players control the supply. Innovation is stifled, and patients pay the price.

Imagine if you could make the cost of research-grade biomaterials more affordable; research institutes would experience a renaissance of life-saving breakthroughs.

HEALTHX20 SOLUTION

HX20 will disrupt the biomaterials industry by accelerating R&D, streamlining raw material sourcing, and scaling the production of regenerative ingredients like Native collagen and Hydroxyapatite. By providing faster, sustainably sourced, and more affordable raw materials, Healthx20 will unlock access for researchers and manufacturers, turbocharging medical breakthroughs, advancing regenerative health, and ultimately saving lives across both developed and underserved markets.